Grabien Mobile App
Get Grabien on the go!

Rep. Biggs: Big Pharma Won’t Consider Therapeutics Like HCQ or Ivermectin Because of Economic Interests

‘You’ve got to look at the money angle’
By Grabien Staff


BIGGS: “Thanks, lisa, good to be with you. I think he’s right, two reasons. Number one, when he talks about big pharma having other economic interests, they got on a path and they want to keep this path there and these other therapeutics aren’t really going to make them a lot of money, so you’ve got to look at the money angle for short. But then you also have to look at the efficacy of big government married to big pharma here and what you see is kind of this power, this control, this move for that. That’s also what’s going on, in my opinion.”

Like our work? Support the cause.